In a separate study, adoptive transfer of haploidentical NK cells, pre-activated overnight with IL-2, showed a partial anti-tumor response in 20% of ovarian and breast cancer patients, and stable disease in 60% of patients [94]. This evidence concerns the gene IL2 and breast carcinoma.